Since current studies indicate possible infection of human lymphocytes with Chlamydia (Chlamydophila) pneumoniae, establishment of an in vitro C. pneumoniae infection model using lymphocyte cell lines was demonstrated. Human lymphoid cell lines (Molt 4 [T-cell] and P3HR1 [B-cell]) were utilized for this purpose besides human monocyte cell line (THP-1) and human epithelial cell line (HEp-2), as a reference of monocyte/macrophage cells and a positive control for support of C. pneumoniae growth, respectively. Both lymphoid cells (Molt 4 and P3HR1) supported the growth of C. pneumoniae as demonstrated by Chlamydia inclusion formation, detection of increased infective progenies and increased bacterial antigen levels. Similar data were obtained using monocyte THP-1 cells. However, the bacterial growth in these cells was less than that in HEp-2 cells. The electron microscopic study showed typical inclusions with many Chlamydia elementary bodies in lymphoid cells tested, similar to that seen in HEp-2 cells. These results indicate that C. pneumoniae can infect cells with lymphocyte properties and this infection model with lymphoid cell line cells could be valuable to study details of lymphocyte^C. pneumoniae interaction.
Introduction
Chlamydia (Chlamydophila) pneumoniae is an obligate intracellular bacterium associated with respiratory tract infections. Current studies indicate that this bacterial infection may be involved in the pathogenesis of atherosclerosis [1] . It has been widely recognized that atherosclerosis is a chronic in£ammatory disease [2] and the formation of the atherosclerotic plaque, which is known to be caused by excessive in£ammatory ¢broproliferation with damage of endothelial and smooth muscle cells [3, 4] , is critical in coronary artery disease. Vasoregulatory molecules, growth factors and cytokines following host immunomodulation have been implicated in this process [5] . In this regard, macrophages and lymphocytes which migrate to in£am-matory sites, such as atherosclerosis lesions, are thought to be the important cells associated with this process [3, 6] .
C. pneumoniae preferentially infects respiratory tract epithelial cells as well as macrophages [7^9] . Moreover, in recent years, the ¢ndings that DNA from this bacterium is detected in the in£ammatory tissues, such as an atherosclerosis lesion, have been reported [10] . This raises the possibility that the development of atherosclerosis is related to immunomodulation due to C. pneumoniae infection of immune cells. Besides epithelial and monocyte/ macrophage cells, it is known that this bacterium multiplies in vitro in endothelial cells and aortic smooth muscle cells [8, 11, 12] . Furthermore, our current study indicates that C. pneumoniae can infect and multiply in lymphocytes in vitro [13] . In this regard, Kaul et al. [14] showed that chlamydia DNA could be recovered from CD3 þ peripheral blood leukocytes obtained from the patients attending a cardiology clinic. These ¢ndings suggest the possibility that lymphocytes may be a host cell for C. pneumoniae. Since lymphocytes are another major immune cell type besides macrophages in the development of atherosclerosis [2] , interaction between lymphocytes and this pathogen may contribute to the pathogenesis of atherosclerosis as well as other chronic in£ammatory diseases associated with C. pneumoniae. For instance, it can be conjectured that activation of lymphocytes by infection with C. pneumoniae may lead to up-regulation of receptors for adhesion molecules on their surfaces as well as production of cytokines, which may contribute to the establishment of in£ammation. In fact, abundant lymphocytes in an activated state are observed in atherosclerotic lesions [15] . Therefore, in order to understand details of lymphocyteĈ . pneumoniae interaction, we attempted to establish an in vitro C. pneumoniae infection model using de¢ned lymphocyte cell line cells and analyzed the growth of this bacterium in lymphocytes by electron microscopy.
Materials and methods

Bacteria
C. pneumoniae TW183 strain was kindly provided by G. Byrne, University of Wisconsin, Madison, WI, USA. The bacterial cultures were con¢rmed Mycoplasma-free by PCR, as described previously [16] . The bacteria were propagated in the HEp-2 cell culture system according to methods described previously [17] . C. pneumoniae elementary bodies (EBs) were puri¢ed by density gradient centrifugation with Percoll (Sigma Chemical, St. Louis, MO, USA) [8] . Puri¢ed EBs were suspended in sucrosep hosphate^glutamic acid bu¡er (0.2 M sucrose, 3.8 mM KH 2 PO 4 , 6.7 mM Na 2 HPO 4 , 5 mM L-glutamic acid, pH 7.4) and then stored at 370 ‡C until used. Inclusion forming units (IFUs) of prepared EBs were determined by counting chlamydial inclusions in HEp-2 cell monolayers [17, 18] . UV-treated bacteria prepared by placing cultures under UV light was also used as a control. The viability of the UV-treated bacteria determined by speci¢c inclusion formation showed that no viable bacteria were detected.
Cell lines
The human epithelial cell line HEp-2 [19] , human monocyte cell line THP-1 [20] and human lymphocyte cell lines Molt 4 (mature T-cell) [21] and P3HR1 (mature B-cell) [22] were kindly provided by R. Widen, Tampa General Hospital, Tampa, FL, USA. The lymphocyte and monocyte cell lines were cultured in RPMI 1640 medium containing 10% heat-inactivated fetal calf serum (FCS) and antibiotics (gentamicin sulfate, 10 Wg ml 31 ; vancomycin, 10 Wg ml 31 ; amphotericin B, 1 Wg ml 31 ) (Sigma) at 37 ‡C in 5% CO 2 . The epithelial HEp-2 cells were cultured in DMEM medium (Sigma) with 10% FCS and antibiotics.
C. pneumoniae infection
Cultures of each cell line (1U10 6 cells) were infected with either viable (1U10 7 IFUs) or UV-treated bacteria (1U10 7 organisms) or cultured without bacteria for 3 h at 37 ‡C in 5% CO 2 with gently shaking. After two washings with medium by centrifugation at 1000 rpm for 10 min, the cultures were re-suspended in medium and then incubated for 72 h in the presence of cycloheximide (Sigma), which was adjusted to speci¢c concentrations as follows: HEp-2, 1 Wg ml 31 ; THP1, 1 Wg ml 31 ; Molt 4, 0.5 Wg ml 31 ; P3HR1, 0.5 Wg ml 31 . The concentrations of cycloheximide used were con¢rmed to show the best chlamydia growth in the cultures in a preliminary study.
Assessment of Chlamydia inclusions
After 3 (immediately after the washing) to 72 h, the cells were collected for determination of the number and morphology of chlamydia inclusions, as described previously [13] . In brief, the cells were centrifuged on a microscopic slide by a Cytospin (Shandon, Sewickley, PA, USA). After ¢xing with ethanol, cells were stained with Chlamydia genus-speci¢c £uorescein isothiocyanate (FITC)-conjugated monoclonal antibody (speci¢c to Chlamydia lipopolysaccharide ; Research Diagnositics, Flanders, NJ, USA). The presence of chlamydia inclusions in the sample was then determined with a £uorescence microscope.
Assessment of infective progeny
To assess the infective progeny in the culture for di¡er-ent time cultivation periods, the cultures were frozen and thawed, as described previously [17] . The lysates in 10-fold serial dilutions were inoculated on HEp-2 cell monolayers in 96-well plates, centrifuged at 800Ug for 60 min, and then incubated in the medium with cycloheximide (1 Wg ml 31 ) for 72 h at 37 ‡C. The number of IFUs in cells was then assessed by staining with FITC-conjugated anti-Chlamydia antibody [8] .
Enzyme-linked immunosorbent assay (ELISA)
Chlamydia lipopolysaccharide (LPS) antigen in cultures was detected by an ELISA kit (IDEIA PCE Chlamydia ; Dako Ltd., Ely, UK), as described previously [13, 23] . Puri¢ed C. pneumoniae EBs were used for preparation of a standard curve. The standard curve permitted quanti¢ca-tion of the number of bacteria from 5U10 4 to 5U10 8 IFUs ml 31 . The results of the ELISA assay were expressed as relative number of bacteria converted from the standard curve.
Electron microscopy
For transmission electron microscopy, the cells were immersed in a ¢xative containing 2.5% glutaraldehyde in 0.1 M phosphate bu¡er (PB), pH 7.4, for 24 h at 4 ‡C and then rinsed in 2.5% sucrose in PB. After a brief rinse in 2.5% sucrose^PB, they were processed for alcohol dehydration and embedding in Epon 813, as described previously [24] . Ultrathin sections of the cells were stained with lead citrate and uranium acetate before viewing on an electron microscope.
Statistical analysis
All experiments were repeated at least three times and the statistical signi¢cance of di¡erence was assessed by unpaired Student's t-test.
Results
Chlamydia inclusion formation
In order to determine whether C. pneumoniae infects and grow in the cells of lymphocyte cell lines, both T-lymphocyte Molt 4 and B-lymphocyte P3HR1 cells were infected with bacteria and assessed for Chlamydia inclusion formation during the cultivation. The monocyte cell line THP-1 was used as a reference for monocytic cells. The epithelial cell line HEp-2 was also used as a control. 
Growth of C. pneumoniae in lymphoid cells
In order to determine quantitatively the growth of C. pneumoniae in the cultures, the amount of bacterial antigen was assessed. As evident in Fig. 2A , the relative numbers of bacteria calculated from the concentrations of bacterial antigen recovered from all cell line cultures were signi¢cantly increased during cultivation for 72 h. The control HEp-2 cells showed the highest amount of bacterial growth, i.e., approximately a 500-fold increase, during the incubation. The P3HR1 showed a marked potency for bacterial growth, which was more than a 80-fold increase, at 72 h after infection. This potent support of C. pneumoniae growth was more than for the monocytic cell line THP-1, which showed approximately a 15-fold increase. The Molt 4 cells showed somewhat less potency for bacterial growth, but the growth was still obvious. These results corresponded to that of microscopic observations. The number of bacteria in cultures infected with UVtreated bacteria showed no increase during the incubation (data not shown).
Demonstration of an increased number of infective progenies in cell cultures is important to establish an in vitro infection model of speci¢c cells with C. pneumoniae. As shown in Fig. 2B , all established cell lines tested showed a signi¢cant increase of infective progenies with a temporary decrease at 24 and 48 h after infection during the cultivation. There were more than 10-fold increases in monocytic as well as lymphoid cells tested at 24 and/or 48 h after infection. In contrast, control HEp-2 cells showed a marked increase of infective progenies during the cultivation, i.e., more than a 100-fold.
Morphological analysis of infected cells
EM studies of infected cells supported the ¢ndings that C. pneumoniae infected and multiplied in the cells of both monocytic and lymphoid cell lines. As shown in Fig. 3 , typical EBs as well as reticulate bodies (RBs) in an inclusion were observed in all cells tested at 72 h after infection. A size of inclusions in lymphoid and monocytic cells was relatively small compared with that in control HEp-2 cells. It is noteworthy that small irregular bodies of chlamydiae in a small inclusion in monocytic and lymphoid cells were observed (Fig. 3E^G) . 
Discussion
In order to understand C. pneumoniae^lymphocyte interaction, utilizing of stable established lymphoid cells for in vitro analysis of a relationship between C. pneumoniae and lymphocytes should be valuable. In the present study, both Molt 4 and P3HR1 lymphoid cells were shown to be valuable as an in vitro infection model of lymphocytes replicating C. pneumoniae. The Molt 4 cell line is widely used as a model for T lymphocytes and shares many features, like cytokine secretion [25] and receptor expression [26] , with normal T cells. Another lymphoid cell line P3HR1 [22] is a model for mature B lymphocytes with surface B cell markers CD10 and CD19 [27] .
Fluorescence microscopic analysis of infected cells with FITC-conjugated anti-Chlamydia antibody revealed that obvious Chlamydia inclusions in cells (Molt 4, P3HR1 and THP-1) could be observed at 72 h after infection. However, the size of the inclusions was relatively small compared with that in epithelial HEp-2 cells, which are widely utilized for propagation of C. pneumoniae. In this regard, it has been shown that the formation of chlamydia inclusions is di¡erent depending on the type of host cells for C. pneumoniae growth, such as HEp-2 cells [17] , HL cells [28] , U937 cells [8] , RAW cells [8] , human endothelial cells [8, 9] , and aortic smooth muscle cells [8] . Therefore, the morphology, including size, of inclusions may re£ect the nature of the host cell.
Since determination of Chlamydia inclusions in cells by staining does not provide much information concerning quantity of bacteria, the amount of bacterial antigen in cultures was measured by ELISA speci¢c for Chlamydia LPS. The relative numbers of bacteria calculated from the concentrations of bacterial antigen recovered from all cell line cultures were signi¢cantly increased during the cultivation for 72 h. The P3HR1 cells showed marked bacterial growth during the incubation. This potent support of C. pneumoniae growth was more than for the monocytic cell line THP-1. The Molt 4 cells showed a little less potency for bacterial growth. In contrast, bacterial growth measured by detection of antigen in epithelial HEp-2 cells was remarkable and was approximately 10 times more than that in P3HR1 cells. These results indicate that all three immune cells tested may be less potent in regards to supporting C. pneumoniae growth in cells compared with that in HEp-2 cells.
The assessment of infective Chlamydia progenies in the cultures provides information as to whether a complete development cycle of C. pneumoniae is achieved in cells. The results indicate an obvious increase of infective progenies in all cells tested during the cultivation for 72 h. As observed in the measurement of bacterial antigen, HEp-2 cells showed a remarkable production of infective progenies during the culture. In contrast, all Molt 4, P3HR1 and THP-1 cells produced much fewer progenies than HEp-2 cells. The levels of progeny were similar among these immune cells. The numbers of bacteria determined by progeny assay were lower than that by the ELISA assay and this may be due to the counting of only infective EBs in the progeny assay. The ratio of the number of infective progenies (number of EBs)/number of bacteria determined by ELISA (number of EBs, RBs plus others) at 72 h after infection was similar between cells tested, including HEp-2 cells (data not shown). That is, the percentage of EBs per total number of bacteria was not much di¡erent between cells tested, indicating there may be no qualitative growth di¡erence. There may be only limited growth in lymphoid and monocytic cells.
Ultrastructural analysis of C. pneumoniae infected lymphoid cells as well as monocytic cells by EM revealed that Chlamydia organisms were located in large inclusions formed in the cytoplasm of the cells at 72 h after infection. The majority of inclusions observed in both lymphoid and monocytic cells contained typical electron dense small EBs, relatively large RBs and some intermediates. These chlamydial particles were the same as that found in HEp-2 cells. However, the size of inclusions in monocytic and lymphoid cells was smaller than those in HEp-2 cells. In particular, many very small inclusions often found in monocytic and lymphoid cells contained a low electron dense particle with irregular shape. Spontaneous abnormal chlamydia bodies have been found in a continuous-infection model [29] . Moreover, chlamydia aberrant bodies were often observed in cells treated with antimicrobial agents and cytokines [29^32] . Even though the irregular shape of chlamydial bodies observed in this study was not similar to that in these previous reports, it seems likely that such irregular bodies in small inclusions observed in monocytic and lymphoid cells may lack a growth potential. These ¢ndings are consistent with the lower number of infective progenies as well as total number of bacteria in monocytic and lymphoid cells than that in HEp-2 cells. The reasons for many small inclusions in immune cells tested are not known, but it may be speculated that monocytic and lymphoid cells may respond to C. pneumoniae infection and produce cytokines, which may control in some degree bacterial growth in the cells. In fact, our current study using alveolar macrophages showed that TNFK production was induced by C. pneumoniae infection and neutralization of TNFK by antibody caused an enhancement of Chlamydia growth in the cells (manuscript in preparation).
There were some di¡erences between B-and T-lymphocyte cell lines regarding support of C. pneumoniae growth, but such di¡erences observed in this study may not be su⁄cient to distinguish di¡erential susceptibility between T-and B-cells to this bacterial infection. Furthermore, since there may be some di¡erences between immortalized cells vs. primary cells, any conclusion from the present results regarding di¡erential susceptibility between T-and B-lymphocytes is not yet unequivocal. Nevertheless, the observations ¢rmly established an in vitro C. pneumoniae infection model using human lymphoid cell lines. This model may be useful in further study regarding the hostp arasite relationship between C. pneumoniae and lymphocytes, which might be essential for understanding the possible involvement of C. pneumoniae infection in the pathogenesis of some chronic in£ammatory diseases, including atherosclerosis.
